Evidence map›Paper›PMID 41487874›Full record

ArticleCureus2025

Hereditary Persistence of Fetal Hemoglobin Presenting With 100% Fetal Hemoglobin and Recurrent Thrombotic Events.

Garry G Lachhar, Salman Syed, Ali Abdullah, Alexandros Konstantinidis, Stephen Pentheros, Alfredo Torres

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Garry G LachharHematology and Oncology, Northwell Health, New York, USA.
Salman SyedInternal Medicine, Northwell Health, New York, USA.
Ali AbdullahInternal Medicine, Northwell Health, New York, USA.
Alexandros KonstantinidisInternal Medicine, Northwell Health, New York, USA.
Stephen PentherosHematology and Oncology, New York Cancer and Blood Specialists, New York, USA.
Alfredo TorresOncology, New York Cancer and Blood Specialists, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fetal hemoglobin (HbF) is the predominant hemoglobin during fetal development, typically replaced by adult hemoglobin after birth. Elevated HbF levels in adulthood are rare and often associated with genetic conditions such as hereditary persistence of fetal hemoglobin (HPFH) or hemoglobinopathies. We present the case of a 30-year-old Pakistani male with 100% HbF, recurrent thrombotic events, including splenic thrombosis and unprovoked pulmonary embolism, and chronic systemic symptoms. Despite extensive evaluation, including bone marrow biopsy, advanced imaging, and multidisciplinary consultations, establishing a definitive diagnosis remained challenging. Genetic testing revealed a homozygous Asian-Indian deletion-inversion in the

Indexed as

asian-indian deletion-inversionbeta-globin genefetal hemoglobinhereditary persistence of fetal hemoglobinthrombosis

Identifiers

PMID41487874
PMCPMC12761339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.